Drug Review Dossiers
Page 1 of 2
1
2
»
Drug Review Dossier: dolutegravir
By
Prevision Policy
|
Published:
1.15.2013
1.15.2013
The FDA/CMS Summit for Biopharma Executives 2012: Summary Notes From December 10-11 Conference
By
Prevision Policy
|
Published:
12.18.2012
12.18.2012
FDA’s OTC Switch Initiative: Slide Deck Attached
By
Prevision Policy
|
Published:
11.27.2012
11.27.2012
The User’s Guide to PDUFA V (PDF Attached)
By
Prevision Policy
|
Published:
9.07.2012
9.07.2012
FDA and AIDS: An Overview — Slide Presentation
By
Prevision Policy
|
Published:
9.01.2012
9.01.2012
Drug Review Dossier: cysteamine bitartrate
By
Prevision Policy
|
Published:
6.30.2012
6.30.2012
Drug Review Dossier: cobicistat
By
Prevision Policy
|
Published:
6.30.2012
6.30.2012
Drug Review Dossier: bedaquiline
By
Prevision Policy
|
Published:
6.30.2012
6.30.2012
Drug Review Dossier: Elvitegravir
By
Prevision Policy
|
Published:
6.30.2012
6.30.2012
Drug Review Dossier: canagliflozin
By
Prevision Policy
|
Published:
5.21.2012
5.21.2012
Drug Review Dossier: Kynamro
By
Prevision Policy
|
Published:
5.21.2012
5.21.2012
Drug Review Dossier: enzalutamide
By
Prevision Policy
|
Published:
5.21.2012
5.21.2012
Drug Review Dossier: Xarelto to Reduce the Risk of Stent Thrombosis in ACS
By
Prevision Policy
|
Published:
4.09.2012
4.09.2012
Drug Review Dossier: Xarelto for DVT, PE, prevention of VTE
By
Prevision Policy
|
Published:
4.03.2012
4.03.2012
Drug Review Dossier: Zohydro
By
Prevision Policy
|
Published:
4.02.2012
4.02.2012
Drug Review Dossier: pomalidomide
By
Prevision Policy
|
Published:
4.01.2012
4.01.2012
Drug Review Dossier: CRTX 800
By
Prevision Policy
|
Published:
3.13.2012
3.13.2012
Drug Review Dossier: lomitapide
By
Prevision Policy
|
Published:
3.06.2012
3.06.2012
Drug Review Dossier: BG-12
By
Prevision Policy
|
Published:
2.28.2012
2.28.2012
Drug Review Dossier: IPX066
By
Prevision Policy
|
Published:
2.23.2012
2.23.2012
Drug Review Dossier: tafamidis meglumine
By
Prevision Policy
|
Published:
2.15.2012
2.15.2012
Drug Review Dossier: crofelemer
By
Prevision Policy
|
Published:
2.09.2012
2.09.2012
Drug Review Dossier: pertuzumab
By
Prevision Policy
|
Published:
2.07.2012
2.07.2012
Drug Review Dossier: Gattex
By
Prevision Policy
|
Published:
1.31.2012
1.31.2012
Drug Review Dossier: bosutinib
By
Prevision Policy
|
Published:
1.27.2012
1.27.2012
Drug Review Dossier: perampanel
By
Prevision Policy
|
Published:
12.26.2011
12.26.2011
Drug Review Dossier: mifepristone for Cushing’s
By
Prevision Policy
|
Published:
12.15.2011
12.15.2011
Drug Review Dossier: apixaban
By
Prevision Policy
|
Published:
11.29.2011
11.29.2011
Drug Review Dossier: Marqibo
By
Prevision Policy
|
Published:
11.21.2011
11.21.2011
Drug Review Dossier: peginesatide
By
Prevision Policy
|
Published:
11.06.2011
11.06.2011
Drug Review Dossier: Axitinib
By
Prevision Policy
|
Published:
11.06.2011
11.06.2011
Drug Review Dossier: Aubagio
By
Prevision Policy
|
Published:
10.20.2011
10.20.2011
Drug Review Dossier: ridaforolimus
By
Prevision Policy
|
Published:
10.05.2011
10.05.2011
Drug Review Dossier: tofactinib
By
Prevision Policy
|
Published:
9.21.2011
9.21.2011
Drug Review Dossier: Northera
By
Prevision Policy
|
Published:
9.17.2011
9.17.2011
Drug Review Dossier: Eylea
By
Prevision Policy
|
Published:
9.01.2011
9.01.2011
Drug Review Dossier: Linaclotide
By
Prevision Policy
|
Published:
7.19.2011
7.19.2011
Avastin Takeaways: Prevision Policy Powerpoint Presentation
By
Prevision Policy
|
Published:
7.15.2011
7.15.2011
Drug Review Dossier: Alogliptin; Fixed-Dose Alogliptin/Pioglitazone Combo
By
Prevision Policy
|
Published:
7.01.2011
7.01.2011
Drug Review Dossier: Aclidinium
By
Prevision Policy
|
Published:
6.19.2011
6.19.2011
Drug Review Dossier: ruxolitinib
By
Prevision Policy
|
Published:
6.16.2011
6.16.2011
Drug Review Dossier: avanafil
By
Prevision Policy
|
Published:
6.01.2011
6.01.2011
Drug Review Dossier: Relistor for OIC in Non-Cancer Pain
By
Prevision Policy
|
Published:
6.01.2011
6.01.2011
Drug Review Dossier: vismodegib
By
Prevision Policy
|
Published:
3.12.2011
3.12.2011
Drug Review Dossier: Xarelto for AFib
By
Prevision Policy
|
Published:
3.06.2011
3.06.2011
Drug Review Dossier: dapagliflozin
By
Prevision Policy
|
Published:
1.30.2011
1.30.2011
Drug Review Dossier: Avastin for Breast Cancer
By
Prevision Policy
|
Published:
1.30.2011
1.30.2011
Drug Review Dossier: mirabegron
By
Prevision Policy
|
Published:
1.30.2011
1.30.2011
Drug Review Dossier: Benlysta
By
Prevision Policy
|
Published:
1.30.2011
1.30.2011
Drug Review Dossier: pixantrone
By
Prevision Policy
|
Published:
10.25.2010
10.25.2010
Page 1 of 2
1
2
»
Member Sign In:
Username
Password
Request New Password
Register to Sign In
Research Notes
No categories
Regulatory Tracking
No categories
All Research
Select Month
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
Prevision Policy
Health Policy + Business Forecasts
Skip to content
Home
Who We Are
Find Us
Drug Review Dossier: dolutegravir